A systematic review of Chinese randomized clinical trials of SSRI treatment of depression

BMC Psychiatry

Volumn 14, Issue 1, 2014, Pages

  Zhang, Ying ^a   Becker, Thomas ^a   Ma, Yongchun ^b   Koesters, Markus ^a  

^a UNIVERSITY OF ULM   (Germany)

^b Tongde Hospital of Zhejiang Province   (China)

Author keywords

Antidepressants; China; Risk of bias assessment; Systematic review

Indexed keywords

CHINESE DRUG; CITALOPRAM; DOPAMINE UPTAKE INHIBITOR; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PLACEBO; SEROTONIN ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ACUPUNCTURE; ARTICLE; CHINESE; CHINESE MEDICINE; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; HAMILTON SCALE; HUMAN; META ANALYSIS; MONOTHERAPY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; REMISSION; SENSITIVITY ANALYSIS; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT EMERGENT SYMPTOM SCALE; TREATMENT RESPONSE; CHINA; DEPRESSIVE DISORDER; DOUBLE BLIND PROCEDURE;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CHINA; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FLUOXETINE; HUMANS; PAROXETINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; SERTRALINE;

EID: 84906833601     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-014-0245-4     Document Type: Article

References (33)

1. Rushton JL, Whitmire JT. Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 2001, 155:560-565. 11343498.
2. Bauer M, Monz BU, Montejo AL, Quail D, Dantchev N, Demyttenaere K, Garcia-Cebrian A, Grassi L, Perahia DG, Reed C, Tylee A. Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry 2008, 23:66-73. 18164600.
3. Sim K, Lee NB, Chua HC. Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. Br J Clin Pharmacol 2007, 63:431-437. 17076698.
4. Uchida N, Chong MY, Tan CH, Nagai H, Tanaka M, Lee MS, Fujii S, Yang SY, Si TM, Sim K, Wei H, Ling HY, Nishimura R, Kawaguchi Y, Edwards G, Sartorius N, Shinfuku N. International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry Clin Neurosci 2007, 61:522-528. 17875031.
5. Zhang Y, Becker T, Koesters M. Preliminary Study of Patterns of Medications Use for Depression Treatment in China. Asia-Pacific Psychiatry 2013, 4:231-236.
6. Koesters M, Zhang Y, Ma YC, Weinmann S, Becker T, Jin WD. What can we learn from chinese randomized controlled trials? A systematic review and meta-analysis of Chinese venlafaxine studies. J Clin Psychopharmacol 2011, 31:194-200. 21346611.
7. Zhang DL, Yin P, Freemantle N, Jordan R, Zhong N, Cheng KK. An assessment of the quality of randomised controlled trials conducted in China. Trials 2008, 9:22. 18435861.
8. Purgato M, Cipriani A, Barbui C. Randomized trials published in Chinese or Western journals. Comparative empirical analysis. J Clin Psychopharmacol 2012, 32:354-361. 22544018.
9. Chen YL, Li J, Ai CL, Duan YR, Wang L, Zhang MM, Hopewell S: Assessment of the Quality of Reporting in Abstracts of Randomised Controlled Trials Published in Five Leading Chinese Medical Journals.PLoS ONE 2010, http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0011926
10. Xu L, Li J, Zhang M, Ai C, Wang L. Chinese authors do need CONSORT: reporting quality assessment for five leading Chinese medical journals. Contemp Clin Trials 2008, 29:723-731.
11. Xia J, Wright J, Adams CE. Five large Chinese biomedical bibliographic databases: accessibility and coverage. Health Info Libr J 2008, 25:55-61. 18251914.
12. National Institute for Health and Clinical Excellence: Depression--The Treatment and Management of Depression in Adults. http://www.nice.org.uk/nicemedia/live/12329/45896.pdf
13. Borenstein M, Hedges L, Higgins J, Rothstein H. Comprehensive meta-analysis 2005, Biostat, NJ.
14. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 12958120.
15. Weinmann S, Becker T, Koesters M. Re-evaluation of the efficacy and tolerability of venlafaxine vs SSRI: meta-analysis. Psychopharmacology (Berl) 2008, 196:511-520.
16. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2., http://www.cochrane-handbook.org/
17. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother 2010, 1:100-107. 21350618.
18. Du YM, Wu RQ, Wang JX. A comparative study of fluoxetine and amitriptyline in the treatment of depressive disorder [Chinese]. Hebei Medical Journal 2006, 28:507.
19. Li B, Wang ZX, Yao FC, Huang MS, Ma C, Sun XL. A double blind controlled trial comparing sertraline and amitriptyline in major depression. Journal of Clinical Psychological Medicine 1996, 6:329-331.
20. Fang LQ, Yang ZC. A comparative study of citalopram and fluoxetine in the treatment of post-stroke depression [Chinese]. Journal of harbin medical university 2007, 41:73-74.
21. Kong YB, Song YP. A clinical observation of citalopram in the treatment of post-stroke depression [Chinese]. J Clin Psychol Med 2004, 14:366-367.
22. Huang P, Li ZR, Wang KY, Cheng B. A double blind comparative study of citalopram in the treatment of post-stroke depression and impact of nerve function rehabilitation [Chinese]. Chin J Nerv Ment Dis 2006, 32:466-467.
23. Fan HT. A study of fluvoxamine in the treatment of post-stroke depression [Chinese]. Chin J Geriatr Heart Brain Vessel Dis 2007, 9:607.
24. Lu XJ. Ma XJ: 170 cases of venlafaxine in the treatment of depression [Chinese]. China Pharmaceuticals 2008, 17:74.
25. Zhang ZQ, Yang XR, Wang XD. A clinical control study of venlafaxine and fluoxetine in the treatment of depression patients. Chinese Journal of Current Clinical Medicine 2004, 2:695-696.
26. Anderson IM. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 2000, 58:19-36. 10760555.
27. Montgomery SA, Henry J, McDonald G, Dinan T, Lader M, Hindmarch I, Clare A, Nutt D. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 1994, 9:47-53. 8195583.
28. Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis. Int Clin Psychopharmacol 1995, 9:33-40. 7622822.
29. Song F, Freemantle N, Sheldon TA, House A, Watson P, Long A, Mason J. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. BMJ 1993, 306:683-687. 8471919.
30. Anderson IM. SSRIs versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depression & Anxiety 1998, 7:11-17. 9597346.
31. Machado M, Iskedjian M, Ruiz I, Einarson TR. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials. Current Medical Research & Opinion 2006, 22:1825-1837.
32. Zhang JZ, Chen HY, Yip KC, Ng R, Wong VT. The effectiveness and safety of acupuncture therapy in depressive disorders: Systematic review and meta-analysis. J Affect Disord 2009. doi:10.1016/j.jad.2009.07.005.
33. Gartlehner G, Hansen RA, Morgan LC, Thaler K, Lux L, Van Noord M, Mager U, Thieda P, Gaynes BN, Wilkins T, Strobelberger M, Lioyd S, Reichenpfader U, Lohr KN. Comparative Benefits and Harms of Second-Generation Antidepressants for Treating Major Depressive Disorder. Ann Intern Med 2011, 155:772-785. 22147715.